1-2 of 2
Peter Noergaard, MD
Close
Sort by
Journal Articles

High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas

Johanne Marie Holst, MD, Maja Ludvigsen, MSc, PhD Ass.prof, Stephen Dutoit, Knud Bendix, Trine Lindhardt Plesner, Peter Noergaard, MD, Michael Boe Møller, Torben Steiniche, Gabriel Rabinovich, PhD, Francesco d'Amore, MD PhD, Martin Bjerregård Pedersen, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4079.
https://doi.org/10.1182/blood.V130.Suppl_1.4079.4079
Published: 2017
Journal Articles

The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK , DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis

Martin Bjerregård Pedersen, MD PhD, Thomas Relander, MD PhD, Grete Fossum Lauritzsen, PhD MD, Fredrik Ellin, MD MSc, Sirpa Leppä, MD PhD, Susanna Mannisto, MD PhD, Esa Jantunen, MD, Rhett P. Ketterling, MD, Patrick Bedroske, BS, Ivy Luoma, BA, Christopher Sattler, BS, Jan M.A. Delabie, MD PhD, Christer Sundstrom, MD, Birgitta Sander, MD PhD, Marja-Liisa Karjalainen-Lindsberg, Stephen Hamilton-Dutoit, MD, Mats Ehinger, MD PhD, M Vornanen, MD, Elisabeth Ralfkiaer, MD DMSC, Rebecca Boddicker, PhD, Nabila Nora Bennani, MD, Naoki Oishi, MD PhD, Michael Boe Moeller, Peter Noergaard, MD, James R. Cerhan, MD PhD, Matthew J Maurer, MS, Knut Liestol, Helle Toldbod, MS,PhD, Andrew L Feldman, MD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 822.
https://doi.org/10.1182/blood.V130.Suppl_1.822.822
Published: 2017